-
Current Status of Novel Therapies for Cerebral Palsy
Prague Symposium of Child Neurology and Developmental Epileptology
Under the auspices of the Charles University and the ICNA
4-5 November 2011, PragueMichael Shevell MDCM FRCP
Departments of Pediatrics and Neurology/Neurosurgery
McGill University
Division of Pediatric Neurology
McGill University Health Centre
Project Lead
Cerebral Palsy Demonstration Project
NeuroDevNet NCE -
Deep brain stimulation reduces pain in children with dystonia, including in dyskinetic cerebral palsy
-
Diversity of the cause of hemiplegic Cerebral Palsy
ICNA/ACNA Children with Cerebral Palsy workshop
Kazuhiro Haginoya MD PhD
Takuto Rehabilitation Center for Children
Japan -
Genetic Contributions to Cerebral Palsy
Presenter: Michael Kruer, MD; Hosted By: CureCP.org
Michael Kruer presents a fascinating look at the medical history of Cerebral Palsy and the latest research around the causes of CP. Lets Cure CP hosted this webinar on October 9th. This is an amazing discussion about the possible genetic link to some forms of Cerebral Palsy. Please enjoy the webinar and share. -
International Cerebral Palsy Genomics Consortium (ICPGC)
In March 2017, the International Cerebral Palsy Genomics Consortium (ICPGC) was formed. It is an unincorporated collaboration among entities and individuals pursuing the common mission of accelerating progress in cerebral palsy genomic research. The consortium aims to achieve this goal by advancing a common infrastructure of genomics and clinical data, and harmonising approaches to enable effective and responsible sharing of genomics and health-related data.
-
Metformin: A Potential Future Treatment for Cerebral Palsy?
Thank you for joining the 2020 Community Forum! To help us plan future forum events, please share your feedback by filling out this short survey: https://www.surveymonkey.com/r/ZXFMR3Q .
2020 Community Forum presented by the Community Council for the American Academy for Cerebral Palsy and Developmental Medicine
Darcy L. Fehlings MD MSc FRCP(C) and Donald Mabbot, PhD discuss their current research trial using the drug Metformin to potentially induce brain repair for children with cerebral palsy. -
MyCP Webinar Series
Each month, Cerebral Palsy Research Network (CPRN) will invite one of its investigators to present their study objectives or findings in a webinar open to the public. Presentations will be 20 minutes in length with an open Q&A following the presentation. Participants must register in advance. Webinars will occur on weeknights at 8 pm ET.